Article 24 Nov 2023 FDA Warning Letters Explained: An Opportunity, Not A Threat United States Healthcare
Article 31 Aug 2023 FDA Issues Second Warning Letter Of 2023 Over Potentially Misleading Efficacy Claims Regarding Inhaler United States Healthcare
Article 18 Aug 2023 FDA Issues Draft Guidance On Pre-market Submissions For Patient-Matched Guides To Orthopedic Implants United States Healthcare
Article 17 Aug 2023 FDA Draft Guidance Recommends Info To Include In Patient-Matched Guides To Orthopedic Implants United States Healthcare
Article 12 Jul 2023 Latest FDA Guidance Includes Minor Procedural Updates To Q-Subs For Medical Devices United States Healthcare
Article 16 Jun 2023 FDA Seeks Input From Life Sciences Industry On Controlling Nitrosamine Impurities United States Healthcare
Article 11 Apr 2023 CMS Issues Initial Guidance On Medicare Drug Price Negotiation Program United States Healthcare
Article 29 Jun 2022 FTC Publishes Proposed Changes To Guides Concerning The Use Of Endorsements And Testimonials In Advertising United States Media & IT
Article 03 May 2022 FDA Issues Guidance On Compounding Animal Drugs From Bulk Drug Substances United States Healthcare
Article 27 Apr 2022 FDA Issues Guidance On Compounding Animal Drugs From Bulk Drug Substances United States Healthcare
Article 18 Mar 2022 FDA Final Guidance On Initiating Voluntary Recalls: Be "Recall Ready" United States Healthcare
Article 14 Feb 2022 District Court Of Delaware Rules For Generic Pharma's Use Of Skinny Label, But Permits Induced Infringement Suit To Proceed Against Insurer United States Healthcare
Article 31 Aug 2021 Federal Circuit's Rehearing Decision Confirms Induced Infringement Even When Skinny Label Was Used United States IP
Article 27 Jul 2021 FDA Issues Final Guidance On Form And Content Of Unique Device Identifier Labeling System United States Healthcare
Article 17 Dec 2020 FDA's Additional Draft Guidance On Biosimilarity And Interchangeability To Seek Comments And Suggestions By January 19, 2021 United States Healthcare
Article 20 Nov 2020 Federal Circuit Holds That, For Venue Purposes, Patent Infringement Occurs Only In Districts Where Actions Related To ANDA Submissions Occur United States IP
Article 04 Nov 2020 Federal Circuit Finds Induced Infringement Of Drug Patent, Even When Skinny Label Was Used United States IP